Washington, D.C. | 22 January 2026 – Sujuan Ba, CEO of the National Foundation for Cancer Research (NFCR), has been named to OncoDaily’s list of the 100 Most Influential CEOs in Oncology in 2025, recognizing leaders whose work is shaping the global cancer research and care ecosystem.
The annual list honors chief executives across industry, academia, policy, healthcare systems, and mission-driven organizations whose leadership has driven measurable and lasting impact in oncology worldwide. Dr. Ba is recognized alongside leaders from major cancer centers, biopharmaceutical companies, research institutions, and global advocacy organizations.
“I am deeply humbled to be included among such an extraordinary group of leaders from across the entire oncology ecosystem and from every region of the world,” said Dr. Ba. “This recognition reflects not only my role, but the commitment, agility, and mission-driven work of the entire NFCR team as we work to advance cancer research globally.”
Under Dr. Ba’s leadership, NFCR has strengthened its role as a strategic accelerator of cancer research, supporting innovative science, fostering cross-sector collaboration, and addressing systemic challenges facing the research ecosystem. The organization’s work spans basic discovery through translational impact, with a focus on enabling solutions that no single institution can achieve alone.
Dr. Ba emphasized that the recognition is about leadership, not labels. “I am honored to be recognized simply as a leader among leaders,” she said. “This moment underscores the importance of stewardship, collaboration, and accountability in advancing progress against cancer.”
OncoDaily’s 100 Most Influential CEOs in Oncology list highlights leaders whose decisions and vision continue to shape the future of cancer research, care, access, and policy worldwide.
For the full list, visit https://oncodaily.com/100/100-most-influential-ceos-438440.
About the National Foundation for Cancer Research
The National Foundation for Cancer Research (NFCR) is a 501(c)(3) nonprofit organization co-founded in 1973 by Nobel Laureate Dr. Albert Szent-Györgyi and attorney/business entrepreneur Franklin Salisbury, Sr. NFCR provides scientists in the lab with the critical seed funding they need to make game-changing discoveries in cancer detection, treatments, prevention, and ultimately, a cure for all cancers. NFCR has distinguished itself in the cancer research sector by emphasizing “high-risk, high-impact” long-term and transformative pioneering research fields often overlooked by other major funding sources. With the support of more than 5.7 million individual donors over the last 50+ years, NFCR has provided more than $420 million in funding to cancer research, prevention, and public education. NFCR-supported research has led to some of the most significant life-saving discoveries that benefit patients today.